These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 20564985)

  • 21. Current Status of Magnetic Resonance Imaging in Patients with Malignant Uterine Neoplasms: A Review.
    Huang YT; Huang YL; Ng KK; Lin G
    Korean J Radiol; 2019 Jan; 20(1):18-33. PubMed ID: 30627019
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Systemic immunity in patients with recurrent vulvovaginal candidiasis].
    Jílek P; Spacek J; Buchta V; Kucera Z; Drahosová M; Förstl M; Andrýs C
    Ceska Gynekol; 2005 Nov; 70(6):453-9. PubMed ID: 17955799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Three patients with differing manifestations of uterine sarcoma].
    Lam JN; Nagel HT; Loyson SA; Peters AA
    Ned Tijdschr Geneeskd; 2006 Feb; 150(6):329-35. PubMed ID: 16503026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of the Immunohistochemical ZEB1 Expression in Uterine Mesenchymal Neoplasms.
    Çelik M; Çelik ZE
    Int J Surg Pathol; 2022 Aug; 30(5):520-527. PubMed ID: 34994578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microsatellite instability in uterine sarcomas.
    Amant F; Dorfling CM; Dreyer L; Vergote I; Lindeque BG; Van Rensburg EJ
    Int J Gynecol Cancer; 2001; 11(3):218-23. PubMed ID: 11437928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Microbiological findings in patients with recurrent vulvovaginal candidiasis in the Hradec Králové Faculty Hospital 1995-2002].
    Buchta V; Spacek J
    Ceska Gynekol; 2004 Jan; 69(1):7-14. PubMed ID: 15112380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma.
    Pautier P; Genestie C; Rey A; Morice P; Roche B; Lhommé C; Haie-Meder C; Duvillard P
    Cancer; 2000 Mar; 88(6):1425-31. PubMed ID: 10717626
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients.
    Abeler VM; Røyne O; Thoresen S; Danielsen HE; Nesland JM; Kristensen GB
    Histopathology; 2009 Feb; 54(3):355-64. PubMed ID: 19236512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Morcellating uterine mesenchymal tumors: The pathologist's view.
    Pavlakis K; Messini I; Yiannou P; Gavresea T; Chrysanthakis D; Hilaris G; Panoskaltsis T
    J Obstet Gynaecol Res; 2017 Mar; 43(3):580-586. PubMed ID: 28120430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cytomorphological diagnosis of nonepithelial tumors of the uterus].
    Novik VI
    Arkh Patol; 1985; 47(8):45-52. PubMed ID: 3000322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Uterine sarcomas: clinical presentation and MRI features.
    Santos P; Cunha TM
    Diagn Interv Radiol; 2015; 21(1):4-9. PubMed ID: 25347940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment, results and prognostic factors in stage I and II sarcomas of the corpus uteri.
    Vongtama V; Karlen JR; Piver SM; Tsukada Y; Moore RH
    AJR Am J Roentgenol; 1976 Jan; 126(1):139-47. PubMed ID: 175673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myxoid Mesenchymal Tumors of the Uterus: An Update on Classification, Definitions, and Differential Diagnosis.
    Busca A; Parra-Herran C
    Adv Anat Pathol; 2017 Nov; 24(6):354-361. PubMed ID: 28787279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Immunohistochemical study of endometrial stromal sarcoma and smooth-muscle tumors of the uterus].
    Farah-Klibi F; Ben Hamouda S; Ben Romdhane S; Sfar R; Koubaa A; Ben Jilani S; Zermani R
    J Gynecol Obstet Biol Reprod (Paris); 2008 Sep; 37(5):457-62. PubMed ID: 18565690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myxoid mixed low-grade endometrial stromal sarcoma and smooth muscle tumor of the uterus. Case report.
    Dundr P; Fischerová D; Povýšil C; Cibula D; Zikán M
    Cesk Patol; 2012 Apr; 48(2):103-6. PubMed ID: 22716064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Highly cellular leiomyoma - A great histopathological masquerader of endometrial stromal sarcoma.
    Garikapati K; Sharmila V; Joshi P; Bharti JN
    J Cancer Res Ther; 2023 Jan; 19(Suppl 2):S943-S945. PubMed ID: 38384086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistochemical evaluation of the c-kit proto-oncogene in sarcomas of the uterus: a case series.
    Leath CA; Straughn JM; Conner MG; Barnes MN; Alvarez RD; Partridge EE; Huh WK
    J Reprod Med; 2004 Feb; 49(2):71-5. PubMed ID: 15018431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical management of uterine sarcomas.
    Amant F; Coosemans A; Debiec-Rychter M; Timmerman D; Vergote I
    Lancet Oncol; 2009 Dec; 10(12):1188-98. PubMed ID: 19959075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical and morphologic diagnosis of uterine sarcoma].
    Bokhman IaV; Urmancheeva AF; Neustadt EL; Kutusheva GF
    Vopr Onkol; 1998; 44(2):175-80. PubMed ID: 9615822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The current staging for uterine body malignancies and its importance for clinical practice].
    Sehnal B; Benková K; Kmoníčková E; Driák D; Spůrková Z; Maxová K; Sláma J
    Cesk Patol; 2014 Apr; 50(2):100-5. PubMed ID: 24758507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.